Differences in lineage replacement dynamics of G1 and G2 rotavirus strains versus G9 strain over a period of 22 years in Bangladesh

Infection, Genetics and Evolution

Volumn 28, Issue , 2014, Pages 214-222

  Afrad, Mokibul Hassan ^a   Matthijnssens, Jelle ^b   Afroz, Syeda Farhana ^a   Rudra, Pranab ^c   Nahar, Lutfun ^a   Rahman, Rajibur ^a   Hossain, Mohammad Enayet ^a   Rahman, Sabita Rezwana ^d   Azim, Tasnim ^a   Rahman, Mustafizur ^a  

^a Virology Laboratory International Centre for Diarrhoeal Disease and Research   (Bangladesh)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c NORTH SOUTH UNIVERSITY   (Bangladesh)

^d UNIVERSITY OF DHAKA   (Bangladesh)

Author keywords

Evolutionary substitution rate; G1; G2; G9; Rotavirus; VP7

Indexed keywords

PROTEIN VP7; CAPSID PROTEIN; VIRUS ANTIGEN; VP7 PROTEIN, ROTAVIRUS;

ARTICLE; BANGLADESH; BAYES THEOREM; CONTROLLED STUDY; GENETIC VARIABILITY; GENOTYPE; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; ROTAVIRUS; STRAIN DIFFERENCE; VIRUS DETECTION; VIRUS GENE; VIRUS MUTATION; VIRUS STRAIN; VP7 GENE; CLASSIFICATION; GASTROENTERITIS; GENETIC SELECTION; GENETICS; HUMAN; INFANT; ISOLATION AND PURIFICATION; PHYLOGENY; PRESCHOOL CHILD; ROTAVIRUS INFECTION; VIROLOGY;

ANTIGENS, VIRAL; BANGLADESH; BAYES THEOREM; CAPSID PROTEINS; CHILD, PRESCHOOL; EVOLUTION, MOLECULAR; GASTROENTERITIS; GENETIC VARIATION; GENOTYPE; HUMANS; INFANT; PHYLOGENY; ROTAVIRUS; ROTAVIRUS INFECTIONS; SELECTION, GENETIC;

EID: 84908370305     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2014.10.002     Document Type: Article

References (51)

1. Afrad M.H., Hassan Z., Farjana S., Moni S., Barua S., Das S.K., Faruque A.S., Azim T., Rahman M. Changing profile of rotavirus genotypes in Bangladesh, 2006-2012. BMC Infect. Dis. 2013, 13:320.
2. Arista S., Giammanco G.M., De Grazia S., Ramirez S., Lo Biundo C., Colomba C., Cascio A., Martella V. Heterogeneity and temporal dynamics of evolution of G1 human rotaviruses in a settled population. J. Virol. 2006, 80:10724-10733.
3. Armah G.E., Sow S.O., Breiman R.F., Dallas M.J., Tapia M.D., Feikin D.R., Binka F.N., Steele A.D., Laserson K.F., Ansah N.A., Levine M.M., Lewis K., Coia M.L., Attah-Poku M., Ojwando J., Rivers S.B., Victor J.C., Nyambane G., Hodgson A., Schodel F., Ciarlet M., Neuzil K.M. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2010, 376:606-614.
4. Banyai K., Laszlo B., Duque J., Steele A.D., Nelson E.A., Gentsch J.R., Parashar U.D. Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs. Vaccine 2012, 30(Suppl. 1):A122-130.
5. Cao D., Barro M., Hoshino Y. Porcine rotavirus bearing an aberrant gene stemming from an intergenic recombination of the NSP2 and NSP5 genes is defective and interfering. J. Virol. 2008, 82:6073-6077.
6. Ciarlet M., Estes M. Rotaviruses: basic biology, epidemiology and methodologies. Encyclopedia of Environmental Microbiology 2002, 2573-2773. John Wiley & Sons, New York. G. Britton (Ed.).
7. Coulson B.S., Kirkwood C. Relation of VP7 amino acid sequence to monoclonal antibody neutralization of rotavirus and rotavirus monotype. J. Virol. 1991, 65:5968-5974.
8. Das S.K., Ahmed S., Ferdous F., Farzana F.D., Chisti M.J., Leung D.T., Malek M.A., Talukder K.A., Bardhan P.K., Salam M.A., Faruque A.S., Raqib R. Changing emergence of Shigella sero-groups in Bangladesh: observation from four different diarrheal disease hospitals. PLoS ONE 2013, 8:e62029.
9. Doan Y.H., Nakagomi T., Cunliffe N.A., Pandey B.D., Sherchand J.B., Nakagomi O. The occurrence of amino acid substitutions D96N and S242N in VP7 of emergent G2P[4] rotaviruses in Nepal in 2004-2005: a global and evolutionary perspective. Arch. Virol. 2011, 156:1969-1978.
10. Domingo E., Holland J.J. RNA virus mutations and fitness for survival. Annu. Rev. Microbiol. 1997, 51:151-178.
11. Donker N.C., Kirkwood C.D. Selection and evolutionary analysis in the nonstructural protein NSP2 of rotavirus A. Infect. Genet. Evol. 2012, 12:1355-1361.
12. Drummond A.J., Rambaut A. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol. Biol. 2007, 7:214.
13. Estes M.K. Rotaviruses 2007, Lippincott Publishers, Philadelphia. 5th ed.
14. Gentsch J.R., Glass R.I., Woods P., Gouvea V., Gorziglia M., Flores J., Das B.K., Bhan M.K. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J. Clin. Microbiol. 1992, 30:1365-1373.
15. Hall T.A. BioEdit: A user-friendly biological sequence alignment editor and analysis program for windows 95/98/NT. Nucleic Acids Symp. Ser. 1999, 41:95-98.
16. Iturriza-Gomara M., Isherwood B., Desselberger U., Gray J. Reassortment in vivo: driving force for diversity of human rotavirus strains isolated in the United Kingdom between 1995 and 1999. J. Virol. 2001, 75:3696-3705.
17. Jenkins G.M., Rambaut A., Pybus O.G., Holmes E.C. Rates of molecular evolution in RNA viruses: a quantitative phylogenetic analysis. J. Mol. Evol. 2002, 54:156-165.
18. Jin Q., Ward R.L., Knowlton D.R., Gabbay Y.B., Linhares A.C., Rappaport R., Woods P.A., Glass R.I., Gentsch J.R. Divergence of VP7 genes of G1 rotaviruses isolated from infants vaccinated with reassortant rhesus rotaviruses. Arch. Virol. 1996, 141:2057-2076.
19. Linhares A.C., Velazquez F.R., Perez-Schael I., Saez-Llorens X., Abate H., Espinoza F., Lopez P., Macias-Parra M., Ortega-Barria E., Rivera-Medina D.M., Rivera L., Pavia-Ruz N., Nunez E., Damaso S., Ruiz-Palacios G.M., De Vos B., O'Ryan M., Gillard P., Bouckenooghe A. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 2008, 371:1181-1189.
20. Madhi S.A., Cunliffe N.A., Steele D., Witte D., Kirsten M., Louw C., Ngwira B., Victor J.C., Gillard P.H., Cheuvart B.B., Han H.H., Neuzil K.M. Effect of human rotavirus vaccine on severe diarrhea in African infants. N. Engl. J. Med. 2010, 362:289-298.
21. Martella V., Banyai K., Matthijnssens J., Buonavoglia C., Ciarlet M. Zoonotic aspects of rotaviruses. Vet. Microbiol. 2010, 140:246-255.
22. Matthijnssens J., Bilcke J., Ciarlet M., Martella V., Banyai K., Rahman M., Zeller M., Beutels P., Van Damme P., Van Ranst M. Rotavirus disease and vaccination: impact on genotype diversity. Future Microbiol. 2009, 4:1303-1316.
23. Matthijnssens J., Ciarlet M., Heiman E., Arijs I., Delbeke T., McDonald S.M., Palombo E.A., Iturriza-Gomara M., Maes P., Patton J.T., Rahman M., Van Ranst M. Full genome-based classification of rotaviruses reveals a common origin between human Wa-Like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains. J. Virol. 2008, 82:3204-3219.
24. Matthijnssens J., Ciarlet M., McDonald S.M., Attoui H., Banyai K., Brister J.R., Buesa J., Esona M.D., Estes M.K., Gentsch J.R., Iturriza-Gomara M., Johne R., Kirkwood C.D., Martella V., Mertens P.P., Nakagomi O., Parreno V., Rahman M., Ruggeri F.M., Saif L.J., Santos N., Steyer A., Taniguchi K., Patton J.T., Desselberger U., Van Ranst M. Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch. Virol. 2011, 156:1397-1413.
25. Matthijnssens J., Heylen E., Zeller M., Rahman M., Lemey P., Van Ranst M. Phylodynamic analyses of rotavirus genotypes G9 and G12 underscore their potential for swift global spread. Mol. Biol. Evol. 2010, 27:2431-2436.
26. Matthijnssens J., Joelsson D.B., Warakomski D.J., Zhou T., Mathis P.K., van Maanen M.H., Ranheim T.S., Ciarlet M. Molecular and biological characterization of the 5 human-bovine rotavirus (WC3)-based reassortant strains of the pentavalent rotavirus vaccine, RotaTeq. Virology 2010, 403:111-127.
27. Matthijnssens J., Nakagomi O., Kirkwood C.D., Ciarlet M., Desselberger U., Van Ranst M. Group A rotavirus universal mass vaccination: how and to what extent will selective pressure influence prevalence of rotavirus genotypes?. Expert Rev. Vaccines 2012, 11:1347-1354.
28. Matthijnssens J., Rahman M., Ciarlet M., Zeller M., Heylen E., Nakagomi T., Uchida R., Hassan Z., Azim T., Nakagomi O., Van Ranst M. Reassortment of human rotavirus gene segments into G11 rotavirus strains. Emerg. Infect. Dis. 2010, 16:625-630.
29. Matthijnssens J., Rahman M., Martella V., Xuelei Y., De Vos S., De Leener K., Ciarlet M., Buonavoglia C., Van Ranst M. Full genomic analysis of human rotavirus strain B4106 and lapine rotavirus strain 30/96 provides evidence for interspecies transmission. J. Virol. 2006, 80:3801-3810.
30. Matthijnssens J., Rahman M., Van Ranst M. Loop model: mechanism to explain partial gene duplications in segmented dsRNA viruses. Biochem. Biophys. Res. Commun. 2006, 340:140-144.
31. Phan T.G., Khamrin P., Quang T.D., Dey S.K., Takanashi S., Okitsu S., Maneekarn N., Ushijima H. Detection and genetic characterization of group A rotavirus strains circulating among children with acute gastroenteritis in Japan. J. Virol. 2007, 81:4645-4653.
32. Pond S.L., Frost S.D., Muse S.V. HyPhy: hypothesis testing using phylogenies. Bioinformatics 2005, 21:676-679.
33. Posada D., Crandall K.A. MODELTEST: testing the model of DNA substitution. Bioinformatics 1998, 14:817-818.
34. Pybus O.G., Rambaut A., Belshaw R., Freckleton R.P., Drummond A.J., Holmes E.C. Phylogenetic evidence for deleterious mutation load in RNA viruses and its contribution to viral evolution. Mol. Biol. Evol. 2007, 24:845-852.
35. Rahman M., Alamgir A.S., Saiada F., Hassan Z., Faruque A.S., Cravioto A., Azim T., Rahman M. Co-circulation of G1, G2 and G9 rotaviruses in hospitalized patients in Bangladesh during 2006-2009. Hum. Vaccin. 2011, 7:929-933.
36. Rahman M., Matthijnssens J., Yang X., Delbeke T., Arijs I., Taniguchi K., Iturriza-Gomara M., Iftekharuddin N., Azim T., Van Ranst M. Evolutionary history and global spread of the emerging g12 human rotaviruses. J. Virol. 2007, 81:2382-2390.
37. Rahman M., Sultana R., Ahmed G., Nahar S., Hassan Z.M., Saiada F., Podder G., Faruque A.S., Siddique A.K., Sack D.A., Matthijnssens J., Van Ranst M., Azim T. Prevalence of G2P[4] and G12P[6] rotavirus, Bangladesh. Emerg. Infect. Dis. 2007, 13:18-24.
38. Ruiz-Palacios G.M., Perez-Schael I., Velazquez F.R., Abate H., Breuer T., Clemens S.C., Cheuvart B., Espinoza F., Gillard P., Innis B.L., Cervantes Y., Linhares A.C., Lopez P., Macias-Parra M., Ortega-Barria E., Richardson V., Rivera-Medina D.M., Rivera L., Salinas B., Pavia-Ruz N., Salmeron J., Ruttimann R., Tinoco J.C., Rubio P., Nunez E., Guerrero M.L., Yarzabal J.P., Damaso S., Tornieporth N., Saez-Llorens X., Vergara R.F., Vesikari T., Bouckenooghe A., Clemens R., De Vos B., O'Ryan M. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N. Engl. J. Med. 2006, 354:11-22.
39. Santos N., Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev. Med. Virol. 2005, 15:29-56.
40. Stoll B.J., Glass R.I., Huq M.I., Khan M.U., Holt J.E., Banu H. Surveillance of patients attending a diarrhoeal disease hospital in Bangladesh. Br. Med. J. (Clin. Res. Ed.) 1982, 285:1185-1188.
41. Tamura K., Peterson D., Peterson N., Stecher G., Nei M., Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 2011, 28:2731-2739.
42. Tate J.E., Burton A.H., Boschi-Pinto C., Steele A.D., Duque J., Parashar U.D. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet. Infect. Dis 2012, 12:136-141.
43. Trang N.V., Yamashiro T., Anh le T.K., Hau V.T., Luan le T., Anh D.D. Genetic variation in the VP7 gene of rotavirus G1P[8] strains isolated in Vietnam, 1998-2009. Virus Res. 2012, 165:190-196.
44. Trojnar E., Sachsenroder J., Twardziok S., Reetz J., Otto P.H., Johne R. Identification of an avian group A rotavirus containing a novel VP4 gene with a close relationship to those of mammalian rotaviruses. J. Gen. Virol. 2013, 94:136-142.
45. Tsugawa T., Hoshino Y. Whole genome sequence and phylogenetic analyses reveal human rotavirus G3P[3] strains Ro1845 and HCR3A are examples of direct virion transmission of canine/feline rotaviruses to humans. Virology 2008, 380:344-353.
46. Unicomb L.E., Bingnan F., Rahim Z., Banu N.N., Gomes J.G., Podder G., Munshi M.H., Tzipori S.R. A one-year survey of rotavirus strains from three locations in Bangladesh. Arch. Virol. 1993, 132:201-208.
47. Unicomb L.E., Podder G., Gentsch J.R., Woods P.A., Hasan K.Z., Faruque A.S., Albert M.J., Glass R.I. Evidence of high-frequency genomic reassortment of group A rotavirus strains in Bangladesh: emergence of type G9 in 1995. J. Clin. Microbiol. 1999, 37:1885-1891.
48. Woelk C.H., Holmes E.C. Reduced positive selection in vector-borne RNA viruses. Mol. Biol. Evol. 2002, 19:2333-2336.
49. Zaman K., Dang D.A., Victor J.C., Shin S., Yunus M., Dallas M.J., Podder G., Vu D.T., Le T.P., Luby S.P., Le H.T., Coia M.L., Lewis K., Rivers S.B., Sack D.A., Schodel F., Steele A.D., Neuzil K.M., Ciarlet M. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010, 376:615-623.
50. Zaman K., Yunus M., Faruque A.S., El Arifeen S., Hossain I., Azim T., Rahman M., Podder G., Roy E., Luby S., Sack D.A. Surveillance of rotavirus in a rural diarrhoea treatment centre in Bangladesh, 2000-2006. Vaccine 2009, 27(Suppl. 5):F31-34.
51. Zeller M., Patton J.T., Heylen E., De Coster S., Ciarlet M., Van Ranst M., Matthijnssens J. Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in Rotarix and RotaTeq. J. Clin. Microbiol. 2012, 50:966-976.